Blood Pressure and Cardiovascular Outcomes in Adults With Diabetes and Chronic Kidney Disease
Open Access
- 7 October 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (19) , e042966
Abstract
Background: Current hypertension guidelines recommend intensive blood pressure (BP) targets (eg, <130/80 mm Hg) for patients with diabetes and chronic kidney disease. However, data supporting these recommendations are limited. Methods: From Korean nationwide health screening and claims data, we identified 373 966 adults with both diabetes and chronic kidney disease who (1) underwent a baseline health examination in 2009 to 2013; (2) had ≥3 BP‐measuring visits during a 5‐year look‐back period; and (3) did not have prior cardiovascular disease (CVD). The mean of all BPs measured throughout the look‐back period was used for the analysis. The primary outcome was CVD event, defined as a composite of myocardial infarction, stroke, heart failure, or death from CVD. Results: Over a median follow‐up of 10.2 years, 40 781 CVD events occurred. When using systolic BP 130 to <140 mm Hg as the reference, multivariable‐adjusted hazard ratios (HRs) for CVD event in the systolic BP ≥150, 140 to <150, 120 to <130, and <120 mm Hg groups were 1.34 (95% CI, 1.29–1.39), 1.11 (95% CI, 1.08–1.14), 0.89 (95% CI, 0.87–0.91), and 0.77 (95% CI, 0.74–0.80), respectively. When using diastolic BP 80 to <90 mm Hg as the reference, HRs in the diastolic BP ≥100, 90 to <100, 70 to <80, and <70 mm Hg groups were 1.70 (95% CI, 1.56–1.85), 1.19 (95% CI, 1.15–1.24), 0.88 (95% CI, 0.86–0.90), and 0.83 (95% CI, 0.80–0.87), respectively. Systolic BP <130 mm Hg and diastolic BP <80 mm Hg were each associated with reduced CVD risk in a log‐linear pattern. Conclusions: Among patients with diabetes and chronic kidney disease, SBP <130 mm Hg and diastolic BP <80 mm Hg were associated with reduced risk of CVD.Keywords
This publication has 36 references indexed in Scilit:
- Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trialThe Lancet, 2024
- Association of Incident Cardiovascular Disease With Time Course and Cumulative Exposure to Multiple Risk FactorsJACC, 2023
- Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With DiabetesJACC, 2022
- Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysisThe Lancet Diabetes & Endocrinology, 2022
- Cardiovascular Implications of the 2021 KDIGO Blood Pressure Guideline for Adults With Chronic Kidney DiseaseJACC, 2022
- On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular HypertrophyJACC, 2021
- KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseKidney International, 2021
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2020
- Hypertension in CKD: Core Curriculum 2019American Journal of Kidney Diseases, 2019
- The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal DiseaseNew England Journal of Medicine, 1994